Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses

18 Aug 2011

Abstract excerpt

The search for a safe and efficacious vaccine for Ebola virus continues, as no current vaccine candidate is nearing licensure. We have developed (i) replication-competent, (ii) replication-deficient, and (iii) chemically inactivated rabies virus (RABV) vaccines expressing Zaire Ebola virus (ZEBOV) glycoprotein (GP) by a reverse genetics system based on the SAD B19 RABV wildlife vaccine. ZEBOV GP is efficiently...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to Viral Infections and Outbreaks Research
Share to Viral Infections and Vectors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21849459
DOI: 10.1128/jvi.00558-11

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola VirusesPMID 21849459Read ↗

rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessmentSemantic proximity Read ↗

Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman PrimatesSemantic proximity Read ↗

Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirusSemantic proximity Read ↗

A novel rabies vaccine based on infectious propagating particles derived from hybrid VEEV-Rabies repliconSemantic proximity Read ↗

Developments in Rabies Vaccines: The Path Traversed from Pasteur to the Modern Era of ImmunizationSemantic proximity Read ↗

Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlifeSemantic proximity Read ↗

Single Immunization With a Monovalent Vesicular Stomatitis Virus–Based Vaccine Protects Nonhuman Primates Against Heterologous Challenge With Bundibugyo ebolavirusSemantic proximity Read ↗

In Vitro and In Vivo Characterization of Recombinant Ebola Viruses Expressing Enhanced Green Fluorescent ProteinSemantic proximity Read ↗

Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus SpeciesSemantic proximity Read ↗

New approaches to the development of live attenuated rabies vaccines.Semantic proximity Read ↗

Development of combined vaccines for rabies and immunocontraceptionSemantic proximity Read ↗

In-Depth Characterization of Live Vaccines Used in Europe for Oral Rabies Vaccination of Wildlife.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.